AKUMS DRUGS & PHARMACEUTICALS
Back to All Ratios
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | 11.98 | 11.18 | 2.94 | 8.04 | -2.50 |
What is the latest Core EBITDA Margin ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2026 | 11.98 |
| Mar2025 | 11.18 |
| Mar2024 | 2.94 |
| Mar2023 | 8.04 |
| Mar2022 | -2.50 |
How is Core EBITDA Margin of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2026 | 11.98 | 7.16 | |
| Mar2025 | 11.18 | 280.27 | |
| Mar2024 | 2.94 | -63.43 | |
| Mar2023 | 8.04 | Positive | |
| Mar2022 | -2.5 | - | |
Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹12,804.5 Cr | -0.7% | 4.4% | 78.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | -0.7% |
4.4% |
78.8% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses